These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24495899)

  • 21. Creating Inquiry Between Technology Developers and Civil Society Actors: Learning from Experiences Around Nanotechnology.
    Krabbenborg L
    Sci Eng Ethics; 2016 Jun; 22(3):907-22. PubMed ID: 26040841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Designing Genopole, a new concept and actor for science, technology and innovation policy in France].
    Branciard A
    Med Sci (Paris); 2009 May; 25 Spec No 2():9-12. PubMed ID: 19852085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What does "Diversity" Mean for Public Engagement in Science? A New Metric for Innovation Ecosystem Diversity.
    Özdemir V; Springer S
    OMICS; 2018 Mar; 22(3):184-189. PubMed ID: 29431577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editorial overview: public science and technology scholars: engaging whom?
    Fisher E
    Sci Eng Ethics; 2011 Dec; 17(4):607-20. PubMed ID: 22113233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Italian parliamentary debates on energy sustainability: How argumentative 'short-circuits' affect public engagement.
    Brondi S; Sarrica M; Caramis A; Piccolo C; Mazzara BM
    Public Underst Sci; 2016 Aug; 25(6):737-53. PubMed ID: 25904600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Science and Postmodernism: From Right-Thinking to Soft-Despotism.
    Kuntz M
    Trends Biotechnol; 2017 Apr; 35(4):283-285. PubMed ID: 28258764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experiments in engagement: Designing public engagement with science and technology for capacity building.
    Selin C; Rawlings KC; de Ridder-Vignone K; Sadowski J; Altamirano Allende C; Gano G; Davies SR; Guston DH
    Public Underst Sci; 2017 Aug; 26(6):634-649. PubMed ID: 26769749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The politicization of science and technology: its implications for nanotechnology.
    Jotterand F
    J Law Med Ethics; 2006; 34(4):658-66. PubMed ID: 17199806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Food, publics, science.
    Blue G
    Public Underst Sci; 2010 Mar; 19(2):147-54. PubMed ID: 20533794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Science to the people! (and experimental politics): searching for the roots of participatory discourse in science and technology in the 1970s in France.
    Quet M
    Public Underst Sci; 2014 Aug; 23(6):628-45. PubMed ID: 23825275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innovation: Bridging the market gap.
    Zappe H
    Nature; 2013 Sep; 501(7468):483-5. PubMed ID: 24073448
    [No Abstract]   [Full Text] [Related]  

  • 32. Nanocommunication design in graduate-level education and research training programs at Osaka University.
    Sekiya M; An S; Ata M
    J Nanopart Res; 2014; 16(9):2595. PubMed ID: 25285034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical modernization, scientific research fields and the epistemic politics of health social movements.
    Hess DJ
    Sociol Health Illn; 2004 Sep; 26(6):695-709. PubMed ID: 15383037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negotiating community engagement and science in the federal environmental public health sector.
    Little PC
    Med Anthropol Q; 2009 Jun; 23(2):94-118. PubMed ID: 19562950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccine research, development, and innovation in Brazil: a translational science perspective.
    Homma A; Tanuri A; Duarte AJ; Marques E; de Almeida A; Martins R; Silva-Junior JB; Possas C
    Vaccine; 2013 Apr; 31 Suppl 2():B54-60. PubMed ID: 23598493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safe and Sound? Scientists' Understandings of Public Engagement in Emerging Biotechnologies.
    Braun M; Starkbaum J; Dabrock P
    PLoS One; 2015; 10(12):e0145033. PubMed ID: 26660160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Navigating the patent landscapes for nanotechnology: English gardens or tangled grounds?
    Sylvester DJ; Bowman DM
    Methods Mol Biol; 2011; 726():359-78. PubMed ID: 21424461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenes and transgressions: scientific dissent as heterogeneous practice.
    Delborne JA
    Soc Stud Sci; 2008 Aug; 38(4):509-41. PubMed ID: 19227618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'Nothing to do with the science': How an elite sociotechnical imaginary cements policy resistance to public perspectives on science and technology through the machinery of government.
    Smallman M
    Soc Stud Sci; 2020 Aug; 50(4):589-608. PubMed ID: 31603380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technoscience, imagined publics and public imaginations.
    Rommetveit K; Wynne B
    Public Underst Sci; 2017 Feb; 26(2):133-147. PubMed ID: 28168940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.